𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Periodontal disease as a risk factor for cardiovascular disease: Suggestion of a further link in systemic lupus erythematosus

✍ Scribed by Larissa Pessoa; Virgilio Galvão; Leopoldo Santos-Neto

Book ID
116746002
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
211 KB
Volume
77
Category
Article
ISSN
0306-9877

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet-activating factor–acetylhydrola
Platelet-activating factor–acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus
✍ Anna Cederholm; Elisabet Svenungsson; Dominique Stengel; Guo-Zhong Fei; A. Graha 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Abstract ## Objective There is an important inflammatory component to atherosclerosis and cardiovascular disease (CVD). It is therefore interesting that the risk of CVD is high in inflammatory diseases such as systemic lupus erythematosus (SLE). In this study, we investigated nontraditional ris

Prevalence of conventional and lupus-spe
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case–control study
✍ Bessant, Rupa ;Duncan, Rachel ;Ambler, Gareth ;Swanton, Jo ;Isenberg, David A. ; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov

Interleukin–1 receptor antagonist gene p
Interleukin–1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
✍ Alexandra I. F. Blakemore; Joanna K. Tarlow; Michael J.Cork; Caroline Gordon; Pa 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

We have previously described associations between an allele of the interleukin-1 receptor antagonist gene (ILlRN) and several inflammatory diseases. In this study we tested the ILlRN gene as a possible marker in patients with systemic lupus erythematosus (SLE). Methods. Eighty-one SLE patients and